COLOMBATTI, ALFONSO
COLOMBATTI, ALFONSO
Emerging Technologies for Cancer Research: towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models
2018 Turetta, Matteo; Ben, Fabio Del; Brisotto, Giulia; Biscontin, Eva; Bulfoni, Michela; Cesselli, Daniela; Colombatti, Alfonso; Scoles, Giacinto; Gigli, Giuseppe; Del Mercato, Loretta L
Lack of T-cell mediated cytotoxicity in M-MSV system depending on H-2 haplotypes.
1979 Biasi, G; Collavo, D; Zanovello, Paola; Colombatti, Alfonso; Chieco Bianchi, L.
Multimerin-2 maintains vascular stability and permeability
2019 Pellicani, R.; Poletto, Elisa; Andreuzzi, E.; Paulitti, A.; Doliana, R.; Bizzotto, D.; Braghetta, P.; Colladel, R.; Tarticchio, G.; Sabatelli, P.; Bucciotti, F.; Bressan, G.; Iozzo, R. V.; Colombatti, A.; Bonaldo, P.; Mongiat, M.
Targeting of EMILIN-1 and EMILIN-2 to Fibrillin Microfibrils Facilitates their Incorporation into the Extracellular Matrix
2016 Schiavinato, Alvise; Keene, Douglas R.; Wohl, Alexander P.; Corallo, Diana; Colombatti, Alfonso; Wagener, Raimund; Paulsson, Mats; Bonaldo, Paolo; Sengle, Gerhard
The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth
2018 Paulitti, Alice; Andreuzzi, Eva; Bizzotto, Dario; Pellicani, Rosanna; Tarticchio, Giulia; Marastoni, Stefano; Pastrello, Chiara; Jurisica, Igor; Ligresti, Giovanni; Bucciotti, Francesco; Doliana, Roberto; Colladel, Roberta; Braghetta, Paola; Poletto, Evelina; Di Silvestre, Alessia; Bressan, Giorgio; Colombatti, Alfonso; Bonaldo, Paolo; Mongiat, Maurizio